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Abstract
Background: Pyogenic hepatic abscesses are relatively rare, though untreated are uniformly fatal. A recent
paradigm shift in the management of liver abscesses, facilitated by advances in diagnostic and interventional
radiology, has decreased mortality rates. The aim of this study was to review our experience in managing pyogenic
liver abscess, review the literature in this field, and propose guidelines to aid in the current management of this
complex disease.
Methods: Demographic and clinical details of all patients admitted to a single institution with liver abscess over a
5 year period were reviewed. Clinical presentation, aetiology, diagnostic work-up, treatment, morbidity and
mortality data were collated.
Results: Over a 5 year period 11 patients presented to a single institution with pyogenic hepatic abscess (55%
males, mean age 60.3 years). Common clinical features at presentation were non-specific constitutional symptoms
and signs. Aetiology was predominantly gallstones (45%) or diverticular disease (27%). In addition to empiric
antimicrobial therapy, all patients underwent radiologically guided percutaneous drainage of the liver abscess at
diagnosis and only 2 patients required surgical intervention, including one 16-year old female who underwent
hemi-hepatectomy for a complex and rare Actinomycotic abscess. There were no mortalities after minimum follow-
up of one year.
Conclusions: Pyogenic liver abscesses are uncommon, and mortality has decreased over the last two decades.
Antimicrobial therapy and radiological intervention form the mainstay of modern treatment. Surgical intervention
should be considered for patients with large, complex, septated or multiple abscesses, underlying disease or in
whom percutaneous drainage has failed.
Background
Pyogenic abscesses account for almost 80% of all liver
abscesses in the developed world and are most often
polymicrobial [1]. Amoebic and fungal abscesses are less
common, and predominantly occur in Southeast Asia
and Africa. Though relatively rare, with a reported inci-
dence of 0.5-0.8% in the Western world and a frequency
of 20 per 100,000 admissions in hospitalized patients,
pyogenic hepatic abscesses are potentially lethal [2].
Hence there is a need to recognize and treat this condi-
tion urgently. The aetiology of these abscesses has
changed over the last few decades. Historically, the
commonest cause had been acute appendicitis but, with
evolution and advancement of surgical practice and
microbiology over time, its frequency as the primary
source of abscess has decreased [3]. In contrast, the
increasing frequency of cholelithiasis and biliary tract
pathology, with their potential to incite ascending portal
sepsis, have replaced appendicitis as the leading cause of
hepatic abscess [2,4,5].
Liver abscess was previously regarded a high morbidity
disease requiring open surgical drainage, with mortality
rates between 9% and 80%. If untreated, it was uni-
formly fatal [4,6,7]. In the last quarter of a century we
have witnessed a major paradigm shift in the manage-
ment of pyogenic hepatic abscesses, with a concomitant
decrease in mortality to 5-30% [8]. Advances in diagnos-
tic and interventional radiology over the last three
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decades have facilitated a minimally invasive approach
to management of this condition. In combination with
targeted antimicrobial therapy, percutaneous drainage
techniques now form the mainstay of treatment. How-
ever, a small proportion of patients do not respond
appropriately to minimally invasive management strate-
gies; it is critical to promptly recognize these patients,
for whom traditional open surgical intervention is the
definitive treatment. We have reviewed our experience
in managing pyogenic liver abscess over the last 5 years,
to illustrate the current etiology, management and out-
comes of this disease. We also reviewed the literature in
this field, and present a summary of current practice
patterns which may serve as a useful guide for the mod-
ern management of pyogenic hepatic abscess.
Methods
Our institution’s ethical committee granted ethical
approval for this study, which was then carried out in
compliance with the Helsinki Declaration. Demographic
and clinical details of all patients admitted to our unit
with liver abscess(es), between June 2004 and June 2009,
were prospectively entered onto a database. Data were
retrieved from a combination of chart review, theatre
records, Hospital In-Patient Enquiry (HIPE) and histo-
pathology databases. A review of these data was per-
formed to document the clinical presentation, aetiology,
diagnostic work-up, treatment, morbidity and mortality.
Radiologically-guided aspiration and drainage of
abscesses was performed under local anaesthesia, with
an 18-gauge needle and a range of different sized drai-
nage catheters (8-12Fr) placed by the Seldinger techni-
que. Pus aspirated at the time of initial abscess drainage
was routinely sent for microbial culture and sensitivity
analysis. Following completion of their treatment regi-
mens, all patients were followed-up clinically and radi-
ologically for at least 1 year to verify abscess resolution.
Results
Clinical presentation
Over a 5-year period, 11 patients presented to our unit
with pyogenic liver abscess. Mean age was 60.27 years
(range 16-85 years); there were 6 males and 5 females.
Underlying comorbidities were present in7 of 11
patients (63.6%) including diabetes (n = 2), hypertension
(n = 3), atrial fibrillation (n = 1), asthma requiring regu-
lar inhaled steroids (n = 1), and 2 patients had a history
of diverticular disease (two patient had more than one
comorbidity at presentation). No patient was taking
immunosuppressant medications. The commonest pre-
senting features were vague non-specific symptoms
including fever (n = 7), right upper quadrant (RUQ)
pain (n = 5), jaundice (n = 3), anorexia and malaise (n =
3). RUQ tenderness and pyrexia were present in the
majority of patients (n = 8). Biochemical and haematolo-
gical findings are documented in Table 1. The most
consistent blood abnormality was an elevated C Reactive
Protein (CRP), which was observed in all cases.
Diagnostic work-up
All patients were initially evaluated with abdominal
ultrasonography (US). Following confirmation of an
abscess in the liver, computed tomography (CT) was
performed to further define its anatomic features, and to
try to determine its aetiology (Figure 1). The sensitivities
of US and CT were 100% in this series. Abscess location
was predominantly in the right lobe of the liver (72% of
patients). Ten patients had a solitary abscess; only one
patient in this series presented with multiple abscess
cavities. All patients proceeded to undergo US-guided
abscess drainage, either at the time of diagnosis or
within 24 hours. Characteristics of these hepatic
abscesses, with corresponding clinical data, are pre-
sented in Table 2.
Aetiology
Gallstones were present on abdominal US in 5 patients
(45.4%) although evidence of acute cholecystitis was
only one present in one of these cases. One patient who
presented with obstructive jaundice had evidence of
intra-hepatic biliary dilatation on US, secondary to com-
pression of the hepatic ductal confluence in the porta
hepatitis by a left lobe abscess. CT scan identified diver-
ticular disease in 3 additional cases (27.2%), without
overt diverticulitis. In the remaining 2 cases there was
no radiologically identifiable cause for liver abscess
(18.2%).
Microbiology
Microbial culture of pus drained from the hepatic
abscess was positive in 7 cases (64%) whilst blood cul-
tures were positive in only 2 cases. Gram positive cocci
(Group B, Group C and Milleri Group Streptococci)
were the most commonly isolated organisms. Coliforms
were isolated in 3 cases (27%). Actinomyces was isolated
from the abscess of a 16 year old Irish girl who had no
history of immunocompromise, foreign travel, recent
abdominal trauma or surgery. PAS and Grocott’s stains
Table 1 Biochemical and haematological derangements
in patients with liver abscess
Biochemical/haematological abnormality % of cases (n)
↑ C-Reactive Protein 100% (11)
↑ White cell count 91% (10)
↑ Liver function tests 82% (9)
Normochromic normocytic anaemia 64% (7)
↑ Serum Creatinine 45% (5)
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demonstrated growth of the actinomyces organisms in
clusters of tangled filaments surrounded by neutrophils
(Figure 2).
Treatment
All patients were empirically commenced on broad
spectrum intravenous antibiotics at presentation. The
most commonly used empiric antimicrobial regimen
was a 3rd generation cephalosporin and metronidazole.
This was changed according to the sensitivities of organ-
isms cultured from each patient’s abscess aspirate or
blood. Ciprofloxacin was used as an alternative to a
cephalosporin in one patient who had a history of peni-
cillin anaphylaxis. All patients underwent radiologically
guided percutaneous drainage of the liver abscess at the
time of diagnosis or within 24 hours of presentation. In
10 cases (91%) a drain was placed in the abscess cavity
and left in-situ following initial aspiration. Duration of
drain placement ranged from 4 to 7 days. The timing of
catheter removal was guided by repeat imaging (US)
demonstrating a significant decrease in abscess size, or
diminution of drain output along with improvement in
clinical condition. One patient with a complex septated
abscess required placement of a second drain after 36
hours, as his clinical condition did not improve and
drain output was minimal. Four patients required trans-
fer to the National Liver Unit as they failed to improve
despite maximal non-operative primary therapy. Two of
these patients (18% of all cases) underwent surgical
intervention. A 61 yr old male, with a 7 cm complex
septated abscess in the right lobe of his liver, underwent
right hemi-hepatectomy due to progressive deterioration
in his clinical condition despite percutaneous catheter
drainage, and a suspicion of malignancy on preoperative
imaging. The second operative case was that of a 16-
year-old Irish female who presented with a two-week
a b
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Figure 1 (a-d) CT images of four patients with hepatic abscesses.
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Table 2 Characteristics of the liver abscesses
Clinical presentation Characteristics of hepatic abscess Management
details




Likely etiology Drain Surgery
1 Male 61 Fever, epigastric pain, anorexia/malaise 5 days Right Single 7 Portal vein
sepsis*
Yes Yes
2 Male 72 Fever, rigors 11 days Left Single 4 Portal vein
sepsis*
Yes No
3 Male 75 Fever, myalgia, pleuritic lower right chest
pain
10 days Right Single 6 Portal vein
sepsis*
Yes No
4 Female 78 Fever, anorexia/malaise 2 weeks Right Single 10 Other^ Yes No
5 Male 85 Anorexia/malaise 4 weeks Right Single 4 Other^ No No
6 Female 56 RUQ pain, nausea 6 weeks Right Single 6 Biliary tract
sepsis
Yes No
7 Female 16 Fever, RUQ pain, jaundice 5 days Right Single 12 Actinomycosis Yes Yes
8 Female 53 RUQ pain 5 days Left Single 7 Biliary tract
sepsis
Yes No
9 Male 33 Fever, jaundice, dark urine 3 days Right Multiple 11 Biliary tract
sepsis
Yes No
10 Male 64 RUQ pain, jaundice 7 days Right Single 5 Biliary tract
sepsis
Yes No
11 Female 70 Fever, RUQ pain 5 days Right Single 10 Biliary tract
sepsis
Yes No
*Portal vein sepsis; secondary to gastrointestinal sources of infection, including diverticulitis and appendicitis.
^Other causes include: hematogenous seeding from a distant site of infection, or unknown etiology.
a b Đ
Ě Ğ Ĩ
Figure 2 Pathological images from two patients with hepatic abscess: (a-b) Demonstrates pathology of a 61yr old male with a 7 cm
abscess, of biliary aetiology, in the right lobe of his liver. (c-f) Gross and microscopic pathological mages from a 16-year-old Irish female who
presented with a 12 cm Actinomycotic abscess in right lobe of liver. (2a) H/E section (x 200 mag) of a pyogenic liver abscess showing
inflammatory cells. (2b) H/E section in higher magnification (x 400 mag) showing acute inflammatory cells forming an abscess. (2c) Section of
liver illustrating a well circumscribed abscess cavity (2d) H/E section (x 200 mag) of a pyogenic liver abscess showing a microabscess with a
central filamentous organism (Actinomycosis) (2e) PAS stain (x 400 mag) highlighting the actinomyces organisms (2f) Grocott stain (x 400 mag)
highlighting the actinomyces organisms (black).
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history of RUQ pain, fever, and anorexia. At presenta-
tion she had profound systemic sepsis. Abdominal US
and CT demonstrated a large (12 cm) complex abscess
in right lobe of liver and despite broad spectrum intra-
venous antibiotics, percutaneous aspiration and drai-
nage, her clinical condition deteriorated and she
underwent right hemi-hepatectomy and cholecystectomy
for a complex Actinomycotic abscess.
Outcome
There were no mortalities in this series. All patients
made a full recovery, and demonstrated evidence of
complete abscess resolution after a minimum of 1-year
follow up. The overall morbidity rate was 45% (n = 5).
Four patients developed severe sepsis with organ dys-
function over the course of their admission. These
patients all required intensive care and transfer to a spe-
cialized hepatobiliary unit for further management. The
young female with a primary Actinomycotic liver
abscess required a 6-month course of oral penicillin
post-operatively. One other patient developed a lower
limb deep venous thrombosis (DVT) despite prophylac-
tic treatment with low molecular weight heparin. Over-
all the mean length of hospital stay for patients
managed non-operatively (n = 9) was 21 days. It was
considerably longer for those patients who underwent
surgical intervention (35 days, on average). All patients
were followed up for minimum of 12 months following
hospital discharge; repeat liver biochemistry and abdom-
inal imaging (US or CT) confirmed abscess resolution in
all cases.
Discussion
Hepatic abscess was first described in the time of Hip-
pocrates around 400B.C. In 1938, Ochsner’s, seminal
review of 47 cases of pyogenic liver abscesses heralded
open surgical drainage as the definitive therapy. This
series highlighted the uniformly fatal outcome of
untreated abscesses. Despite the recommended aggres-
sive approach to treatment, mortality rates throughout
the mid twentieth century remained high at 60-80%.
Advances in diagnostic and therapeutic radiology,
coupled with improvements in microbiological identifi-
cation and therapy, have recently decreased mortality
rates to <5-30% [2]. In our series of 11 patients, there
were no deaths and morbidity rate was 45%.
With the development of more sophisticated diagnos-
tic techniques and longer lifespan, the demographic for
peak incidence of liver abscess is shifting towards the
sixth and seventh decades of life [9]. Liver abscesses are
rare in children and adolescents, and are usually asso-
ciated with an underlying immune deficiency state or
trauma. Clinical presentation of pyogenic hepatic
abscess is non-specific and similar to that of other
hepatobiliary inflammatory or infectious process. A
combination of nonspecific systemic symptoms is the
most common presentation; including fever and rigors,
nausea and vomiting, right upper quadrant pain, anor-
exia, weight loss, weakness and malaise. Less frequently
reported symptoms include cough or hiccups due to
diaphragmatic irritation, with referred pain to the right
shoulder. Patients with small solitary lesions usually
have a more insidious course with associated weight
loss, fatigue and anaemia of chronic disease. With such
symptoms, malignancy is often the initial concern. Mul-
tiple abscesses usually result in more acute presenta-
tions, as reflected by the one case in this series with
multiple abscesses who presented after a short 3 day ill-
ness, with symptoms and signs of systemic toxicity [3,9].
Regarding laboratory abnormalities associated with
hepatic abscesses, elevated inflammatory markers are
sensitive but non-specific. In our series, we observed
raised CRP in all cases. With regard to liver biochemis-
try, an elevated ALP is the single most common finding,
observed in up to 90% of cases. Approximately 50% of
patients demonstrate a general derangement of liver bio-
chemistry, including elevated serum bilirubin, and hepa-
tic enzymes AST and ALT. Other haematological
abnormalities include leucocytosis and normochromic
normocytic anaemia. Blood cultures are positive in less
than 50% of cases [9]; we observed positive blood cul-
tures in only 18% of our case series. Definitive diagnosis
requires radiological evidence of an abscess in the liver
parenchyma. Ultrasonography and computed tomogra-
phy of the abdomen are the gold standard diagnostic
modalities. In addition, they have therapeutic utility as
they are employed to guide percutaneous aspiration and
drainage of an abscess. These radiological investigations
may also reveal the underlying aetiology, for example a
contiguous infection within the biliary tree or peritoneal
cavity.
Although the incidence of pyogenic liver abscess has
remained relatively unchanged over time, the underlying
aetiology has changed in unison with developments in
surgical and microbiology practices. Biliary tract disease
has replaced appendicitis as the commonest cause of
bacterial liver abscess [4]. Chole(docho)lithiasis,
obstructing tumours, strictures, and congenital anoma-
lies of the biliary tree, are common causative conditions.
An alternative mechanism for liver abscess formation,
apart from direct spread from contiguous infection, is
embolisation of a septic coagulum from an intra-abdom-
inal infection. Diverticulitis, inflammatory bowel disease
and perforated hollow viscera are possible sources of
septic emboli in addition to appendicitis. Rarely, abscess
formation results from haematogenous dissemination of
organisms in association with a systemic bacteraemia, e.
g. from endocarditis or pyelonephritis. Such cases have
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been reported in immunocompromised individuals with
chronic granulomatous disease and leukemia [5]. Our
series reflected this changing trend in aetiology; with a
biliary source in 45%, diverticular aetiology in 27.5%,
and likely haematogenous dissemination in the remain-
ing 27.5% of patients. The organisms isolated from a
liver abscess are varied, usually polymicrobial, and
reflective of the infectious source (Table 3). Whilst this
study and review focused primarily on bacterial causes
of liver abscess, it should be noted that parasitic organ-
isms are also common etiological factors, particularly in
tropical and subtropical climates. Entamoeba histolytica
and the nematode Ascaris lumbricoides are two such
parasites associated with liver abscess formation, and
should be considered in patients from endemic areas
[1,10,11].
Untreated, pyogenic hepatic abscess is uniformly fatal
due to ensuing complications such as sepsis, or perito-
nitis secondary to rupture of the abscess cavity into
the pleural or peritoneal cavities. Systemic antimicro-
bial therapy remains the mainstay primary treatment.
The choice of empiric antibiotics is based on the most
likely source of infection, but should be broad spec-
trum and administered parenterally. The regimen must
be reviewed and altered, if appropriate, to target speci-
fic organisms isolated from the abscess aspirate and/or
blood cultures. The recommended duration of parent-
eral antibiotic therapy is 2-3 weeks, or until there is a
favourable clinical response. Complementary oral anti-
microbial therapy must then be continued for a further
2-4 weeks or until clinical, biochemical and radiologi-
cal follow-up demonstrates complete resolution of the
abscess cavity. Evidence suggests that antibiotic ther-
apy alone is usually not sufficient to entirely resolve a
liver abscess unless it is small (<3 cm) [12,13]. If anti-
biotics are selected as the sole therapeutic modality,
then a prolonged course of systemic and oral therapy
is warranted, and the choice of antimicrobial agent
must be guided by the sensitivities of causative
organisms [14,15]. There is debate however as to the
size of abscess above which antibiotic treatment alone
is unlikely to be successful. Malik et al recently
reported their experience of managing 169 pyogenic
liver abscesses, 16 of which were treated with intrave-
nous antibiotics alone for 2 weeks [10]. This conserva-
tive approach was successful in only 6 of the 16
patients; the remaining 10 required open surgical drai-
nage for definitive control of sepsis. The authors’ cri-
teria for choosing antibiotics as the single therapeutic
modality were an uncomplicated abscess, <6 cm in
size. The authors’ low success rates with this approach
provide support for draining abscesses smaller than
6 cm, as recommended by Krige et al [1]. Indeed var-
ious reports suggest that any abscess larger than 3 cm
should be routinely drained [13,16,17]. In addition to
abscess size, other criteria for percutaneous drainage
include: continued pyrexia after 48-72 h of adequate
medical treatment, and clinical or ultrasonographic
features suggest impending perforation [10,18].
Surgical drainage is associated with high therapeutic
success rates, and was the standard of care until the
introduction of percutaneous drainage techniques in the
mid 1970s. With refinement of image-guided techniques
in recent years, percutaneous drainage and aspiration
have emerged as appropriate alternatives to open drai-
nage, providing similarly high success rates but with the
advantages of a minimally invasive approach[19-21]. The
decision to leave a drainage catheter in the abscess cav-
ity following aspiration, rather than performing repeated
needle aspirations, is also contentious. Those who prefer
multiple aspirations believe it to be as effective and safe
as catheter drainage, but simpler and quicker to per-
form, with decreased risk of procedural complications
and post-procedural sepsis [17,22,23]. However, this
approach requires careful follow-up, and often multiple
repeat imaging procedures to monitor response to ther-
apy. Insertion of a drainage catheter has been shown to
be more effective than needle aspiration, particularly for
abscesses larger than 5 cm. Failure rates are higher, and
the average time to achieve a 50% reduction in size of
an abscess cavity has been shown to be significantly
longer, with needle aspiration compared to abscesses in
which a drainage catheter has been placed [17,22].
Despite the reported success of percutaneous drainage
techniques, there remains a role for open surgical inter-
vention in the management of pyogenic abscess. Indica-
tions for surgical intervention include:
■ No clinical response after 4-7 days of drainage via
a catheter placed in the abscess cavity.
■ Multiple, large, or loculated abscess
■ Thick walled abscess with viscous pus
■ Concurrent intra-abdominal surgical pathology.
Table 3 Causative organisms of hepatic abscess
Source of infection Common Organism








Single organism usually e.g. Staphylococcus,
Streptococcus (including Strep. milleri)
Immunocompromised Candida species
Other Pyogenic: Klebsiella pneumoniae (Asia),
Actinomyces (rare).
Amebic: Entamoeba histolytica (Amebic
abscess),
Parasitic: Ascaris lumbricoides
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Bertel et al [24] compared open surgery with percuta-
neous drainage for the management of pyogenic liver
abscesses greater than 5 cm. Whilst morbidity was com-
parable for both approaches, those who underwent open
surgical resection/drainage required fewer secondary
procedures, and achieved higher rates of abscess resolu-
tion. Very recently, it has been shown that using multi-
detector CT to analyze abscesses could identify factors
predictive of percutaneous drainage failure [25]. The
strongest predictor of failure included the presence of
gas in the abscess. Other notable factors were an abscess
size greater than 7.3 cm, and a short length to the liver
capsule of <0.25 cm. In the setting of failed percuta-
neous drainage of a liver abscess, another consideration
prior to proceeding with open surgery is laparoscopic
drainage. Aydin et al systematically reviewed the litera-
ture describing experience with this approach, and iden-
tified 53 cases of liver abscess treated by laparoscopy.
The overall success rate was 90.5%, and no reported
case required conversion to open [26]. From their
review of this data, the authors concluded that laparo-
scopic surgery has the advantages of high success rates
of open surgery, and the minimal invasiveness of percu-
taneous drainage. In light of this, it should be consid-
ered as an alternative before open drainage, when other
modalities have failed.
Actinomycotic liver abscess
Primary actinomycotic liver abscess is extremely rare. In
this series, we include the first report to our knowledge
of this type of liver abscess in Ireland and the United
Kingdom. Actinomycosis is a chronic suppurative granu-
lomatous disease characterized by abscess formation, tis-
sue fibrosis and discharging sinuses. The actinomyces
organism is a gram-positive, semi-facultative, pleo-
morphic non-spore-forming, non-acid-fast bacillus of
the genus Actinomyces. The most common presentation
of this disease is infection of the oral and cervicofacial
region. However, the thoracic region, abdomino-pelvic
region and CNS are also frequently involved. Although
actinomyces species are part of the normal oral and gut
flora, (where they have low pathogenicity) any disrup-
tion of the gastrointestinal mucosal barrier can lead to
disease. Once the organism breaches mucosal barriers
and is established locally, it is notoriously pathogenic
and spread of infection has no regard for anatomic
planes or boundaries. The few previously described
cases of actinomycotic GI infection have occurred where
there has been a loss of mucosal integrity, as occurs
with surgery, appendicitis, diverticulitis, trauma, or for-
eign bodies including intrauterine contraceptive devices
[27,28]. Possible causes of hepatic infection by actino-
myces include disseminated infection from oral disease
via the hepatic artery, from intra-abdominal disease via
the portal vein, or from direct extension of a subdiaph-
ragmatic or subhepatic process. However, in the major-
ity of cases no cause is identifiable, as in our case. The
16 year old female in this series had no history of for-
eign travel, infectious contacts, past medical or surgical
illness, abdominal trauma or foreign body in-situ. In
addition, her dental hygiene was good, and she had no
evidence of oral or cervical infection. Culture of the
organism is difficult; it requires anaerobic or microaero-
phillic conditions, gram stain of the organism, haema-
toxylin-eosin stain of the ‘sulfur granules’, or more
specific stains such as Grocott-Gomori methenamine-
silver nitrate stain and P-aminosalicylic acid (Figure 2e
&2f). Management of an actinomycotic liver abscess
should follow the general principles described above,
primarily with antimicrobial agents and abscess drai-
nage. Actinomyces is sensitive to penicillin; the recom-
mended course for hepatic actinomycosis is parenteral
penicillin for 2-6 weeks, followed by oral therapy with
penicillin or amoxicillin for 6-12 months [29]. Drainage
of these liver abscesses is guided by their size, complex-
ity and the clinical condition of the patient. Our patient
required transfer to a specialized liver unit for surgical
management because of clinical deterioration despite
maximal non-operative therapy. Following hemi-hepa-
tectomy and the recommended course of penicillin
based systemic therapy she made an excellent recovery
and remains well after 36 months.
Conclusion
Although our series of hepatic abscess cases is small,
there are few reports in recent years of outcomes with
modern management techniques and thus our experi-
ence may provide valuable information to clinicians who
encounter this uncommon condition. In particular, the
rare case of an actinomycotic liver abscess in a healthy
Irish female is interesting and noteworthy. Based on our
review of existing literature and our experience to date,
we propose the following summary to guide the man-
agement of pyogenic hepatic abscess:
1. Prompt administration of empiric broad spectrum
parenteral antibiotics
2. Ultrasound and/or CT scan to confirm diagnosis,
with simultaneous radiologically guided aspiration of
all abscesses >3 cm, +/- drain placement.
3. Microbiological analysis of abscess aspirates and
blood cultures: antibiotic regimen should be adjusted
according to culture results and sensitivities.
4. Early recognition of septicaemia or organ failure
and appropriate transfer to critical care unit. Con-
sider repeat imaging to confirm correct drain place-
ment and to determine response to treatment and
final resolution of the abscess.
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5. Surgical intervention should be considered for
patients with large, complex, septated or multiple
abscesses, underlying disease or in whom percuta-
neous drainage has failed.
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